Table 2.
Significant total effects (outside parentheses) and indirect effects (inside parentheses) resulting from the final mediational model
| Outcome variables | PGWBI | PWB | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Predictor variables | Overall (latent variable) | Lack of illness | Healthy enough to do things | Lack of health concern | Anxiety | Depressed mood | Positive well‐being | Self‐control | Vitality | Overall (latent variable) | Environmental mastery | Personal growth | Positive relations | Purpose in life | Self‐acceptance |
| Stigma | |||||||||||||||
| Perceived social avoidance | −.16 (−.03) | −.05 (−.05) | .07 (.07) | −.06 (−.06) | −.13 (−.13) | −.14 (−.14) | −.14 (−.14) | −.13 (−.13) | −.14 (−.14) | −.04 (−.04) | −.03 (−.03) | −.02 (−.02) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) |
| Anticipated self‐blame | −.04 (−.04) | −.01 (−.01) | .02 (.02) | −.01 (−.01) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) | −.05 (−.05) | −.04 (−.04) | −.03 (−.03) | −.03 (−.03) | −.04 (−.04) | −.04 (−.04) |
| Anticipated negative social judgement | – | – | – | – | – | – | – | – | – | −.23 | −.21 (−.21) | −.14 (−.14) | −.16 (−.16) | −.18 (−.18) | −.20 (−.20) |
| COVID | |||||||||||||||
| Threat | −.05 (−.05) | −.02 (−.02) | .02 (.02) | −.02 (−.02) | −.04 (−.04) | −.04 (−.04) | −.04 (−.04) | −.04 (−.04) | −.05 (−.05) | −.06 (−.06) | −.06 (−.06) | −.04 (−.04) | −.04 (−.04) | −.05 (−.05) | −.05 (−.05) |
| Financial impact | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Resources impact | −.06 (−.06) | −.02 (−.02) | .03 (.03) | −.02 (−.02) | −.05 (−.05) | −.05 (−.05) | −.05 (−.05) | −.05 (−.05) | −.05 (−.05) | −.07 (−.07) | −.07 (−.07) | −.04 (−.04) | −.05 (−.05) | −.06 (−.06) | −.06 (−.06) |
| Psychological impact | −.27 | −.08 (−.08) | .11 (.11) | −.09 (−.09) | −.21 (−.21) | −.22 (−.22) | −.22 (−.22) | −.21 (−.21) | −.23 (−.23) | −.32 | −.29 (−.29) | −.19 (−.19) | −.22 (−.22) | −.25 (−.25) | −.28 (−.28) |
| Exposure to C news | −.04 (−.04) | −.01 (−.01) | .02 (.02) | −.01 (−.01) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) | −.03 (−.03) | −.05 (−.05) | −.04 (−.04) | −.03 (−.03) | −.03 (−.03) | −.04 (−.04) | −.04 (−.04) |
| C‐like symptoms | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Sickness | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Negative C swab | – | – | – | – | – | – | – | – | – | .14 | .12 (.12) | .08 (.08) | .09 (.09) | .11 (.11) | .12 (.12) |
Values reported refer to standardized effects significant at p < .05.